Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Med-Chemist |
Description | Contributors Med-Chemist : "Quintessential Medicinal Chemistry" Monday, January 23, 2023 FDA Approves Iyuzeh (latanoprost ophthalmic solution) for the Reduction of Ele |
Keywords | N/A |
WebSite | med-chemist.com |
Host IP | 216.239.32.21 |
Location | United States |
Site | Rank |
US$598,759
Last updated: 2023-05-09 11:31:14
med-chemist.com has Semrush global rank of 17,677,073. med-chemist.com has an estimated worth of US$ 598,759, based on its estimated Ads revenue. med-chemist.com receives approximately 69,088 unique visitors each day. Its web server is located in United States, with IP address 216.239.32.21. According to SiteAdvisor, med-chemist.com is safe to visit. |
Purchase/Sale Value | US$598,759 |
Daily Ads Revenue | US$553 |
Monthly Ads Revenue | US$16,582 |
Yearly Ads Revenue | US$198,973 |
Daily Unique Visitors | 4,606 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
med-chemist.com. | A | 7199 | IP: 216.239.32.21 |
med-chemist.com. | A | 7199 | IP: 216.239.36.21 |
med-chemist.com. | A | 7199 | IP: 216.239.34.21 |
med-chemist.com. | A | 7199 | IP: 216.239.38.21 |
med-chemist.com. | NS | 38400 | NS Record: dns4.bigrock.in. |
med-chemist.com. | NS | 38400 | NS Record: dns3.bigrock.in. |
med-chemist.com. | NS | 38400 | NS Record: dns2.bigrock.in. |
med-chemist.com. | NS | 38400 | NS Record: dns1.bigrock.in. |
med-chemist.com. | MX | 38400 | MX Record: 100 us2.mx3.mailhostbox.com. |
med-chemist.com. | MX | 38400 | MX Record: 100 us2.mx1.mailhostbox.com. |
med-chemist.com. | MX | 38400 | MX Record: 100 us2.mx2.mailhostbox.com. |
med-chemist.com. | TXT | 38400 | TXT Record: v=spf1 redirect=_spf.mailhostbox.com |
Med-Chemist : "Quintessential Medicinal Chemistry" Monday, January 23, 2023 FDA Approves Iyuzeh (latanoprost ophthalmic solution) for the Reduction of Elevated Intraocular Pressure (IOP) in Patients with Open-Angle Glaucoma or Ocular Hypertension › In continuation of my update on Latanoprost Thea Pharma, Inc. (“Thea”), the U.S. subsidiary of Europe’s leading independent pharmaceutical... Friday, January 20, 2023 FDA Approves Rezlidhia (olutasidenib) for Relapsed or Refractory Acute Myeloid Leukemia with a Susceptible IDH1 Mutation › Rigel Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) approval of Rezlidhia (olutasidenib) capsules for the t... Thursday, January 19, 2023 FDA Approves Krazati (adagrasib) for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation › Mirati Therapeutics, Inc. (NASDAQ: MRTX), a targeted oncology company, announced the U.S. Food and Drug Administration (FDA) approval of ... Wednesday, January |
HTTP/1.1 404 Not Found Date: Sun, 31 Oct 2021 19:06:27 GMT Content-Type: text/html; charset=UTF-8 Server: ghs Content-Length: 1561 X-XSS-Protection: 0 X-Frame-Options: SAMEORIGIN |
Domain Name: MED-CHEMIST.COM Registry Domain ID: 1605075427_DOMAIN_COM-VRSN Registrar WHOIS Server: Whois.bigrock.com Registrar URL: http://www.bigrock.com Updated Date: 2021-06-10T10:42:27Z Creation Date: 2010-07-05T04:56:28Z Registry Expiry Date: 2022-07-05T04:56:28Z Registrar: BigRock Solutions Ltd Registrar IANA ID: 1495 Registrar Abuse Contact Email: abuse@bigrock.com Registrar Abuse Contact Phone: +1.832-295-1535 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS1.BIGROCK.IN Name Server: DNS2.BIGROCK.IN Name Server: DNS3.BIGROCK.IN Name Server: DNS4.BIGROCK.IN DNSSEC: unsigned >>> Last update of whois database: 2021-09-19T04:56:01Z <<< |